AKT1 and cancer: Additionally, CD38 increases the phosphorylation of PI3K, AKT, and mTORC and upregulates the PI3K/AKT/mTOR pathway, which is related to metabolic reprogramming and proliferation of cancer cells, while such effects were significantly reversed with mTOR inhibitor, rapamycin [49, 50].